Johns Hopkins University and the University of Maryland at College Park are conducting a clinical trial to test a new herpes vaccine. The vaccine is for women who do not already have oral or genital herpes, and is intended to reduce the risk that they will acquire the disease. This is a Stage III trial, the final testing stage before seeking FDA approval. The trial involves several thousand participants at 20 medical institutions.

For details, go to http://www.niaid.nih.gov/dmid/stds/herpevac/studyover%5Ffaqs.htm or call:
Karen at Johns Hopkins (410) 955-2530
Pam Welch or Jan Cowan at University of Maryland (301) 314-7575